Cases & Deals

Pfizer acquires Angiosyn, a biopharmaceutical company

Clients Pfizer, Inc.

Jones Day acted as principal outside tax counsel to Pfizer in its agreed acquisition of Angiosyn, a biopharmaceutical company focused on the discovery and development of technology to ward off blindness.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.